Docking and ADME/T analysis of silibinin as a potential inhibitor of EGFR kinase for ovarian cancer therapy.
Article
de En
| IMSEAR
| ID: sea-180332
Texte intégral:
1
Indice:
IMSEAR
Type d'étude:
Prognostic_studies
langue:
En
Année:
2016
Type:
Article